Çöpür M, Çöpür S (2020) Risperidone and hepatotoxicity in children and adolescent: a literature review. Kıbrıs Türk Psikiyatri ve Psikoloji Dergisi 2:54–58

Google Scholar 

The British Pharmacopoeia (2022) Medicines and Healthcare products Regulatory Agency, London.

Heym J, Koe BK (1988) Pharmacology of sertraline: a review. J Clin Psychiatry 49:40–45

PubMed  Google Scholar 

Dolder C, Nelson M, Deyo Z (2008) Paliperidone for schizophrenia. Am J Health-Syst Pharm 65:403–413

Article  CAS  PubMed  Google Scholar 

Corena-McLeod M (2015) Comparative pharmacology of risperidone and paliperidone. Drugs R D 15:163–174

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yoshimura R, Umene-Nakano W, Ueda N, Ikenouchi-Sugita A, Hori H, Nakamura J (2008) Addition of risperidone to sertraline improves sertraline-resistant refractory depression without influencing plasma concentrations of sertraline and desmethylsertraline. Hum Psychopharmacol Clin Exp 23:707–713

Article  CAS  Google Scholar 

Yoshimura R, Ikenouchi-Sugita A, Hori H, Umene-Nakano W, Katsuki A, Hayashi K, Ueda N, Nakamura J (2010) Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression. Prog Neuropsychopharmacol Biol Psychiatry 34:308–312

Article  CAS  PubMed  Google Scholar 

Phillips ML, Kupfer DJ (2013) Bipolar disorder diagnosis: challenges and future directions. Lancet 381:1663–1671

Article  PubMed  PubMed Central  Google Scholar 

Lang X, Xue M, Zang X, Wu F, Xiu M, Zhang X (2023) Efficacy of low-dose risperidone in combination with sertraline in first-episode drug-naïve patients with schizophrenia: a randomized controlled open-label study. J Transl Med 21:432

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang P, Si T (2013) Use of antipsychotics in the treatment of depressive disorders. Shanghai Arch Psychiatry 25:134

CAS  PubMed  PubMed Central  Google Scholar 

Hodkinson A, Heneghan C, Mahtani KR, Kontopantelis E, Panagioti M (2021) Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports. BMC Med 19:195

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spina E, D’Arrigo C, Migliardi G, Morgante L, Zoccali R, Ancione M, Madia A (2004) Plasma risperidone concentrations during combined treatment with sertraline. Ther Drug Monit 26:386–390

Article  CAS  PubMed  Google Scholar 

Chen D, Jiang S, Chen Y, Hu Y (2004) HPLC determination of sertraline in bulk drug, tablets and capsules using hydroxypropyl-β-cyclodextrin as mobile phase additive. J Pharm Biomed Anal 34:239–245

Article  CAS  PubMed  Google Scholar 

Ferrarini A, Huidobro AL, Pellati F, Barbas C (2010) Development and validation of a HPLC method for the determination of sertraline and three non-chiral related impurities. J Pharm Biomed Anal 53:122–129

Article  CAS  PubMed  Google Scholar 

Baldania SL, Bhatt KK, Mehta RS, Shah DA (2008) RP-HPLC estimation of risperidone in tablet dosage forms. Indian J Pharm Sci 70:494

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raggi MA, Bugamelli F, Sabbioni C, Saracino MA, Petio C (2005) HPLC-DAD determination of plasma levels of the antipsychotic risperidone and its main metabolite for toxicological purposes. J Sep Sci 28:245–250

Article  CAS  PubMed  Google Scholar 

Sharma D, Srinivas KS, Gupta P, Dwivedi DP, Dureja H, Nagpal M, Rakha P, Goyal S (2010) Simultaneous estimation of risperidone, olanzapine and quetiapine and their degradation products by HPLC. Acta Pharm Sci 52:345–352

CAS  Google Scholar 

Rao KN, Ganapaty S, Rao AL (2013) Development and validation of new HPLC method for the estimation of paliperidone in pharmaceutical dosage forms. Rasayan J Chem 6:34–38

CAS  Google Scholar 

Umamahesswar K, Ramu G, Rambabu C (2013) A reverse phase HPLC method development and validation for the determination of paliperidone in pure and dosage forms. Chem Sci Trans 2:41–46

Article  Google Scholar 

Pyka-Pająk A (2022) New TLC method combined with densitometry for determination of Sertraline and Fluoxetine in pharmaceutical preparations. Processes 10:2083

Article  Google Scholar 

Vahora S, Chhalotiya UK, Kachhiya H, Tandel J, Shah D (2021) Simultaneous quantification of brexpiprazole and sertraline HCl in synthetic mixture by thin-layer chromatography method. JPC-J Planar Chromat 34:549–557

Article  CAS  Google Scholar 

Patel SK, Patel NJ (2009) TLC determination of amitriptyline HCl, trifluoperazine HCl, risperidone and alprazolam in pharmaceutical products. Chromatographia 69:393–396

Article  CAS  Google Scholar 

El-Sherif ZA, El-Zeany B, El-Houssini OM (2005) High performance liquid chromatographic and thin layer densitometric methods for the determination of risperidone in the presence of its degradation products in bulk powder and in tablets. J Pharm Biomed Anal 36:975–981

Article  CAS  PubMed  Google Scholar 

Patel RB, Patel MR, Bhatt KK, Patel BG (2010) HPTLC method development and validation: quantification of paliperidone in formulations and in vitro release study. Anal Methods 2:525–531

Article  CAS  Google Scholar 

Alam P, Shakeel F, Alshehri S, Alhaiti A, Alqarni MH, Foudah AI, Aljarba TM (2024) Analysis of the greenness to determine risperidone in commercial products using a green stability-indicating HPTLC method. Arab J Chem 17:105693

Article  CAS  Google Scholar 

Darwish IA (2005) Development and validation of spectrophotometric methods for determination of fluoxetine, sertraline, and paroxetine in pharmaceutical dosage forms. J AOAC Int 88:38–45

Article  CAS  PubMed  Google Scholar 

Amin A, Dessouki H, Moustafa M, Ghoname M (2009) Spectrophotometric methods for sertraline hydrochloride and/or clidinium bromide determination in bulk and pharmaceutical preparations. Chem Pap 63:716–722

Article  CAS  Google Scholar 

Kumar MS, Smith AA, Vasagam GA, Muthu AK, Manavalan R (2010) Development of analytical method for risperidone by UV spectrophotometry. Int J Pharm Sci Res 1:122–126

Google Scholar 

Jayanna BK, Devaraj TD, Roopa KP, Nagendrappa G, Kumar HA, Gowda N (2014) Spectrophotometric estimation of risperidone in tablets. Indian J Pharm Sci 76:452

CAS  PubMed  PubMed Central  Google Scholar 

Mendez AS, Cassol PE, Brum de Camargo V, DonadelMalesuik M, Garcia CV (2014) Quantitative determination of paliperidone in OROS® tablets by derivative spectrophotometric method-application in extraction and comparison to HPLC. Curr Anal Chem 10(1):158–165

Article  CAS  Google Scholar 

Korrapati U, Chintala R (2014) Spectrophotometric methods for the quantitative estimation of paliperidone in formulations. Chem Sci Trans 3:1156–1162

Google Scholar 

El-Enany NM, Abdelal A, Belal F (2011) Spectrofluorimetric determination of sertraline in dosage forms and human plasma through derivatization with 9-fluorenylmethyl chloroformate. Chem Cent J 5:1–8

Article  Google Scholar 

Izadyar A, Arachchige DR, Cornwell H, Hershberger JC (2016) Ion transfer stripping voltammetry for the detection of nanomolar levels of fluoxetine, citalopram, and sertraline in tap and river water samples. Sens Actuators B Chem 223:226–233

Article  CAS  Google Scholar 

Vela MH, Quinaz Garcia MB, Montenegro MCBSM (2001) Electrochemical behaviour of sertraline at a hanging mercury drop electrode and its determination in pharmaceutical products. Fresenius J Anal Chem 369:563–566

Article  CAS  PubMed  Google Scholar 

Taşdemir IH, Çakirer O, Erk N, Kiliç E (2011) Square-wave cathodic adsorptive stripping voltammetry of risperidone. Collect Czech Chem Commun 76:159–176

Article  Google Scholar 

Afkhami A, Ghaedi H (2012) Multiwalled carbon nanotube paste electrode as an easy, inexpensive and highly selective sensor for voltammetric determination of Risperidone. Anal Methods 4:1415–1420

Article  CAS